211 related articles for article (PubMed ID: 12944405)
21. A binding site for thrombin in the apple 1 domain of factor XI.
Baglia FA; Walsh PN
J Biol Chem; 1996 Feb; 271(7):3652-8. PubMed ID: 8631976
[TBL] [Abstract][Full Text] [Related]
22. Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential.
Gailani D; Ho D; Sun MF; Cheng Q; Walsh PN
Blood; 2001 May; 97(10):3117-22. PubMed ID: 11342438
[TBL] [Abstract][Full Text] [Related]
23. Activated platelets but not endothelial cells participate in the initiation of the consolidation phase of blood coagulation.
Baird TR; Walsh PN
J Biol Chem; 2002 Aug; 277(32):28498-503. PubMed ID: 12029092
[TBL] [Abstract][Full Text] [Related]
24. High-molecular-weight kininogen is exclusively membrane bound on endothelial cells to influence activation of vascular endothelium.
Hasan AA; Cines DB; Ngaiza JR; Jaffe EA; Schmaier AH
Blood; 1995 Jun; 85(11):3134-43. PubMed ID: 7756645
[TBL] [Abstract][Full Text] [Related]
25. Activation of the plasma kinin forming cascade along cell surfaces.
Kaplan AP; Joseph K; Shibayama Y; Reddigari S; Ghebrehiwet B
Int Arch Allergy Immunol; 2001; 124(1-3):339-42. PubMed ID: 11307009
[TBL] [Abstract][Full Text] [Related]
26. Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R).
Joseph K; Ghebrehiwet B; Peerschke EI; Reid KB; Kaplan AP
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8552-7. PubMed ID: 8710908
[TBL] [Abstract][Full Text] [Related]
27. Interaction of factor XII and high molecular weight kininogen with cytokeratin 1 and gC1qR of vascular endothelial cells and with aggregated Abeta protein of Alzheimer's disease.
Joseph K; Shibayama Y; Nakazawa Y; Peerschke EI; Ghebrehiwet B; Kaplan AP
Immunopharmacology; 1999 Sep; 43(2-3):203-10. PubMed ID: 10596854
[TBL] [Abstract][Full Text] [Related]
28. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
29. Anti-HK antibody inhibits the plasma contact system by blocking prekallikrein and factor XI activation in vivo.
Chen ZL; Singh PK; Horn K; Calvano MR; Kaneki S; McCrae KR; Strickland S; Norris EH
Blood Adv; 2023 Apr; 7(7):1156-1167. PubMed ID: 36409609
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator.
Shariat-Madar Z; Mahdi F; Schmaier AH
J Biol Chem; 2002 May; 277(20):17962-9. PubMed ID: 11830581
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa.
Geng Y; Verhamme IM; Sun MF; Bajaj SP; Emsley J; Gailani D
J Thromb Haemost; 2013 Jul; 11(7):1374-84. PubMed ID: 23617568
[TBL] [Abstract][Full Text] [Related]
32. Factor XII does not initiate prekallikrein activation on endothelial cells.
Røjkjaer R; Hasan AA; Motta G; Schousboe I; Schmaier AH
Thromb Haemost; 1998 Jul; 80(1):74-81. PubMed ID: 9684789
[TBL] [Abstract][Full Text] [Related]
33. Contact factors in plasma from women on oral contraception--significance of factor XI for the measured activity of factor XII.
Fossum S; Hoem NO; Johannesen S; Korpberget M; Nylund E; Sandem S; Briseid K
Thromb Res; 1994 Jun; 74(5):477-85. PubMed ID: 8085248
[TBL] [Abstract][Full Text] [Related]
34. Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms.
Singh PK; Chen ZL; Horn K; Norris EH
Res Pract Thromb Haemost; 2022 Oct; 6(7):e12815. PubMed ID: 36254255
[TBL] [Abstract][Full Text] [Related]
35. Identification of a binding site for glycoprotein Ibalpha in the Apple 3 domain of factor XI.
Baglia FA; Gailani D; López JA; Walsh PN
J Biol Chem; 2004 Oct; 279(44):45470-6. PubMed ID: 15317813
[TBL] [Abstract][Full Text] [Related]
36. Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease.
Merlo C; Wuillemin WA; Redondo M; Furlan M; Sulzer I; Kremer-Hovinga J; Binder BR; Lämmle B
Atherosclerosis; 2002 Apr; 161(2):261-7. PubMed ID: 11888508
[TBL] [Abstract][Full Text] [Related]
37. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
Sugi T; McIntyre JA
J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858
[TBL] [Abstract][Full Text] [Related]
38. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
Baglia FA; Walsh PN
Biochemistry; 1998 Feb; 37(8):2271-81. PubMed ID: 9485373
[TBL] [Abstract][Full Text] [Related]
39. Hydrogen-deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa.
Bar Barroeta A; van Galen J; Stroo I; Marquart JA; Meijer AB; Meijers JCM
J Thromb Haemost; 2019 Dec; 17(12):2047-2055. PubMed ID: 31519061
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a heparin binding site on the heavy chain of factor XI.
Zhao M; Abdel-Razek T; Sun MF; Gailani D
J Biol Chem; 1998 Nov; 273(47):31153-9. PubMed ID: 9813019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
